Advertisement
Screener

CARIS LIFE SCIENCES, INC. (CAI) Long-Term Debt

CARIS LIFE SCIENCES, INC. Long-Term Debt

CARIS LIFE SCIENCES, INC. (CAI) had Long-Term Debt of $392.97 million as of 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation

us-gaap:LongTermDebtNoncurrent · last filed 2026-08-05

  • 2026-06-30: Long-term Debt, Excluding Current Maturities $392.97M.
  • 2026-03-31: Long-term Debt, Excluding Current Maturities $381.40M.
  • 2025-12-31: Long-term Debt, Excluding Current Maturities $378.82M.
  • 2025-09-30: Long-term Debt, Excluding Current Maturities $376.30M.
Period endLong-term Debt, Excluding Current Maturities
2026-06-30$392.97M
10-Q · filed 2026-08-05
2026-03-31$381.40M
10-Q · filed 2026-05-08
2025-12-31$378.82M
10-Q · filed 2026-08-05
2025-09-30$376.30M
10-Q · filed 2025-11-05
2025-06-30$373.61M
10-Q · filed 2025-08-12
2024-12-31$319.44M
10-K · filed 2026-03-03

Similar stocks

Stock NameCountryMarket CapPE Ratio
RadNet, Inc. (RDNT)United States$5.611B-229.65
GRAIL, Inc. (GRAL)United States$5.591B-7.78
VERACYTE, INC. (VCYT)United States$3.904B41.21
Celcuity Inc. (CELC)United States$3.887B-22.62
CareDx, Inc. (CDNA)United States$3.174B13.21
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70